Christoph Bruening
Corporate Officer/Principal bei Value Relations GmbH
Aktive Positionen von Christoph Bruening
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Value Relations GmbH | Corporate Officer/Principal | 01.01.1999 | - |
Karriereverlauf von Christoph Bruening
Ehemalige bekannte Positionen von Christoph Bruening
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.05.2003 | 26.05.2010 |
Statistik
International
| Vereinigte Staaten | 2 |
| Deutschland | 2 |
Operativ
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Value Relations GmbH |
- Börse
- Insiders
- Christoph Bruening
- Erfahrung
